Pharmaceuticals

New diabetes drug better for weight loss than Ozempic: research

News Hour Correspondent - Sep 23, 2023

A study of the literature published on Saturday found that a new diabetic medication promotes greater weight loss and lower blood sugar levels than its well-known competition semaglutide, better known as Ozempic. Tirzepatide, marketed by US...
Stablepharma Team expands to progress development of the World’s First Fridge-free Tetanus diphtheria vaccine

News Hour Correspondent - Aug 9, 2023

Stablepharma Ltd is delighted to announce two new members who will join the Advisory Board with immediate effect – Richard Lane, an experienced corporate lawyer and Dr Ceri Morgan, Senior Advisor & NED, specialising in capital...
Stablepharma and Partner BB-NCIPD Ltd sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine

News Hour Correspondent - Jul 4, 2023

Stablepharma Ltd, the Fridge-free Vaccine Company, and the European vaccine maker BB-NCIPD Ltd (Bul Bio) have inked a second agreement for the exclusive bulk supply and commercialization of the Tetanus vaccine (SPVX06). This partnership follows a...
Japan approves abortion pill for the first time

News Hour Correspondent - Apr 29, 2023

After the health ministry approved the drug used to terminate early-stage pregnancy, the abortion pill will be made available in Japan for the first time. Abortion is allowed in Japan up to 22 weeks, however, consent...
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity

News Hour Correspondent - Apr 14, 2023

Aspect Biosystems and Novo Nordisk A/S today announced a collaboration, development, and licence agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body with the aim of delivering a...
Pfizer’s ZAVZPRET migraine nasal spray receives FDA approval

News Hour Correspondent - Mar 11, 2023

ZAVZPRET (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults, has been authorized by the U.S. Food and Drug Administration...
US drugmaker Eli Lilly says slashing insulin prices

News Hour Correspondent - Mar 2, 2023

Eli Lilly, a major US pharmaceutical company, declared on Wednesday that it would reduce the price of its insulin by 70%, and President Joe Biden urged others to do the same to combat rising drug costs....
US FDA clears path for pharmacies to sell abortion pills

Mridha Shihab Mahmud - Jan 4, 2023

According to a new rule change by the Biden administration, retail pharmacies in the US can now dispense the abortion drug mifepristone. Mifepristone is currently only available in person from a medical professional as one of...
Johnson & Johnson completes acquisition of Abiomed

News Hour Correspondent - Dec 26, 2022

Johnson & Johnson announced it has completed its acquisition of Abiomed, Inc. Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment. “We are excited...
VidPrevtyn Beta COVID-19 booster vaccine, developed by Sanofi and GSK, approved for use in Great Britain

News Hour Correspondent - Dec 26, 2022

GSK plc announced the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) authorized Sanofi’s SARS-CoV-2 spike protein (B.1.351 strain) vaccine for the prevention of COVID-19 disease in adults aged 18 and above in Great Britain,...